Kristina Sjöblom Nygren joined Santhera as Chief Medical Officer (CMO) and Head of Development and member of Santhera’s Executive Management Team effective January 1, 2017. Kristina studied chemistry and biochemistry and graduated as a medical doctor from the Karolinska Institute, Sweden. She brings over 18 years of experience as biopharmaceutical executive in drug development across multiple therapeutic areas, including orphan diseases. During her career she has worked in clinical development roles at Wyeth, AstraZeneca and Biovitrum. Prior to joining Santhera Kristina served as VP and Head of Clinical Development at Sobi where she was leading the clinical development of all programs from first in man to commercialization and life cycle management.